Trial site
Guizhou Cancer Hospital
Guiyang, Guizhou 550000, ChinaNot linked to an institution yet
The trials here
What the 5 trials at this site are about, from their registry records.
- Status
- Active, not recruiting5 trials
- Lead sponsor
- Akeso2 trials
- Jiangsu HengRui Medicine Co., Ltd.2 trials
- Hoffmann-La Roche1 trial
Running trials
Active, not recruiting
A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
NCT05954910· Hoffmann-La Roche· Source
Active, not recruiting
A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer
NCT05235516· Phase 3· Akeso· Source
Active, not recruiting
A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
NCT04974398· Phase 3· Akeso· Source
Active, not recruiting
A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation
NCT04639180· Phase 3· Jiangsu HengRui Medicine Co., Ltd.· Source
Active, not recruiting
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT04691804· Phase 3· Jiangsu HengRui Medicine Co., Ltd.· Source
Report an error